Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland

NCT03582098 · clinicaltrials.gov ↗

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Lymphocytic Leukaemia

Interventions

DRUG: Idelalisib
DRUG: Rituximab

Sponsor

Gilead Sciences